Frazier Life Sciences Management LP

Search
⚲

Frazier Life Sciences Management LP ✚
CRD #	317522
SEC #	801-122904
CIK #
AUM	6,966.9 M (2026-03-31)
Employees	64 (73% Investors, 0% Brokers)
Fees
Minimum
Phone	650-325-5156
Address	1001 Page Mill Road Palo Alto, CA 94304
Source	[IAPD] [Website] [LinkedIn]

Total AUM ($B) Copy

Type	Form D Funds	Date	Sold	AUM
VC	Frazier Life Sciences XII LP	[2025-03-31]		1,350.6 M
	Filed 2025-03-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Not Applicable
HF	Frazier Life Sciences Public Overage Fund LP	[2023-03-31]	243.1 M	362.2 M
	Offered $243,146,976 · Filed 2022-04-14 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $3,968 · Duration One year or less · Revenue Decline to Disclose
HF	Frazier Life Sciences Public Fund LP	[2022-03-31]		2,868.0 M
	Offered $617,050,000 · Filed 2019-12-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $617,050,000 · Duration One year or less · Revenue Not Applicable
VC	Frazier Life Sciences Xi LP	[2022-03-31]	960.0 M	1,107.8 M
	Offered $960,000,000 · Filed 2022-03-18 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable
PE	Frazier Life Sciences X LP	[2020-03-30]		781.2 M
	Offered $617,050,000 · Filed 2019-12-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $617,050,000 · Duration One year or less · Revenue Not Applicable
VC	Frazier Life Sciences IX LP	[2018-03-30]	418.9 M	596.5 M
	Offered $418,925,000 · Filed 2017-11-01 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Not Applicable
VC	Frazier Life Sciences VIII LP	[2016-03-29]	262.0 M	260.2 M
	Offered $262,000,000 · Filed 2015-10-29 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $68,750 · Duration One year or less · Revenue Not Applicable

AUM Breakdown	Accounts	AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	8	7.0
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	8	7.0
By Discretionary
Discretionary	8	7.0
Non-Discretionary	0	0.0
Total	8	7.0
By Non-United States Persons
Non-United States Persons		0.0
United States Persons		7.0
Total	8	7.0

Form D Directors	Role	# Filings	# Firms
Patrick Heron	Executive Officer	59	3
James Topper	Executive Officer	58	3
Nader Naini	Promoter	43	3
Nathan Every	Promoter	41	3
Steve Bailey	Executive Officer	23	3
Alan Frazier	Promoter	16	3
Daniel Estes	Executive Officer, Promoter	10	2
Frazier Management LLC	Promoter	6	2
Fhmlsp Overage LP	Promoter	2	2
Fhmlsp Overage LLC	Promoter	2	2
Fhm Life Sciences VIII LLC	Executive Officer	1	1
Fhmls IX LLC	Executive Officer	1	1
Fhmls IX LP	Executive Officer	1	1
Fhm Life Sciences VIII LP	Executive Officer	1	1

Firm Profile (Form ADV)
Serves	Institutional
Fund Types	Hedge Fund, Private Equity
LEI	254900K7JVMHHKW0QH33

Comparable Firms	State	AUM
Arbour Lane Capital Management LP ✚	CT	7,297.3 M
Peak Rock Capital LLC ✚	TX	7,275.0 M
Caspian Capital LP ✚	NY	7,026.2 M
Tilden Park Capital Management LP ✚	NY	6,836.6 M
First Sentier Investors Australia RE Ltd ✚		6,826.5 M
Atairos Management LP ✚	PA	6,786.2 M
Lead Edge Capital Management LLC ✚	NY	6,766.5 M
Discovery Capital Management LLC ✚	CT	6,748.6 M
BC Partners Advisors LP ✚	NY	6,688.9 M
NXT Capital Investment Advisers LLC ✚	IL	6,647.9 M

Frazier Life Sciences Management LP

Assets, Funds, Holdings